What question did this study set out to answer?

The study aims to evaluate cystathionine as a metabolic marker for differentiating adult-type diffuse gliomas, specifically oligodendrogliomas and astrocytomas.

February 9, 2026

The Utility of Cystathionine Assessment using proton MR Spectroscopy for the Preoperative Differential Diagnosis of Adult-Type Diffuse Gliomas.

Key Points

The study aims to evaluate cystathionine as a metabolic marker for differentiating adult-type diffuse gliomas, specifically oligodendrogliomas and astrocytomas.
Quantification of cystathionine using proton MR spectroscopy (1H-MRS)
Comparison of cystathionine levels among various glioma subtypes
Evaluation of cystathionine in conjunction with 2HG and imaging features
Higher cystathionine levels are associated with oligodendrogliomas compared to astrocytomas
Cystathionine alone cannot reliably distinguish between glioma subtypes due to overlap with glioblastomas
When combined with 2HG and imaging, cystathionine enhances subtype classification for preoperative diagnoses

Abstract

Cystathionine quantification by 1H-MRS reflects biologically meaningful metabolic differences among adult-type diffuse gliomas, with higher levels characteristic of oligodendrogliomas compared with astrocytomas. However, overlap with glioblastomas limits its role as a stand-alone discriminator. When interpreted alongside 2HG and conventional imaging features, cystathionine may serve as a supportive metabolic marker to enhance preoperative glioma subtype classification.

Ask AI

Mark Helpful

Bookmark

Relay